Ginkgo Bioworks Holdings Inc Class (DNA)
EBITDA Margin
-216.35%
TTM · Period ending:
DNA EBITDA Margin
Latest reported-216.35%period ending
Latest reported-216.35%period ending
DNA TTM EBITDA Margin (-149.08% → -216.35%)
TTM ebitda margin
High-resolution chart · PNG
DNA ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -216.3477% | |
| -172.4784% | |
| -146.1726% | |
| -179.6579% | |
| -126.9298% | |
| -163.2528% | |
| -208.0099% | |
| -283.8799% | |
| -408.363% | |
| -367.8352% | |
| -318.3786% | |
| -203.7164% | |
| -347.84% | |
| -420.1973% | |
| -426.2649% | |
| -663.4381% | |
| -544.3673% | |
| -529.8474% | |
| -575.7425% | |
| -132.549% | |
| -142.7348% | |
| -171.2457% | |
| -149.0771% |